Nachrichten und Videos - NOVANTA INC. - Seite 2

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the second quarter 2022. Financial Highlights Three Months Ended (In millions, except per share amounts) July 1, July 2, 2022 2021 GAAP Revenue $ 215.4 $ 167.5 Operating Income $ 23.3 $ 16.0 Consolidated Net Income $ 17.5 $ 11.7 Diluted EPS $ 0.49 $ 0.33 Non-GAAP* Adjusted Operating Income $ 36.7 $ 28.7 Adjusted Diluted EPS...

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2022 results on Tuesday, August 9, 2022. The Company will host a conference call on Tuesday, August 9, 2022, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the...

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the CJS Securities 22 nd Annual “New Ideas” Summer Conference on Tuesday, July 12, 2022, which is being held in Greenwich, CT. About Novanta Novanta is a leading global supplier of core technology solutions that give...

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird's 2022 Global Consumer, Technology & Services Conference on Tuesday, June 7, 2022, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers (“OEMs”) a...

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and Charlie Webster, Executive Vice President, are scheduled to present at the William Blair 42 nd Annual Growth Stock Conference on Monday, June 6, 2022, in Chicago, IL. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original...

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the first quarter 2022. Financial Highlights Three Months Ended (In millions, except per share amounts) April 1, April 2, 2022 2021 GAAP Revenue $ 204.2 $ 162.6 Operating Income $ 24.3 $ 11.1 Consolidated Net Income $ 18.8 $ 11.3 Diluted EPS $ 0.53 $ 0.32 Non-GAAP* Adjusted Operating Income $ 33.5 $ 22.8 Adjusted Diluted...

Celera Motion, an award-winning business unit of Novanta Inc., today announced new sizes and capabilities for its Aura TM Absolute Chip Encoder Series of rotary and linear optical encoders with MicroE technology. The new Aura encoder line extension products will meet all the typical sizes needed in a robot arm, from small end effectors at the end of the arm to the upper shoulder joints. “This new product will be an incredibly precise and highly accurate encoder in a small package to meet...

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2022 results on Tuesday, May 10, 2022. The Company will host a conference call on Tuesday, May 10, 2022, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events &...

Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the fourth quarter and full year 2021. Financial Highlights Three Months Ended December 31, Year Ended December 31, (In millions, except per share amounts) 2021 2020 2021 2020 GAAP Revenue $ 199.0 $ 147.5 $ 706.8 $ 590.6 Operating Income $ 21.7 $ 17.1 $ 64.1 $ 55.9 Net Income $ 13.8 $ 12.7 $ 50.3 $ 44.5...

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter and full year 2021 results on Tuesday, March 01, 2022. The Company will host a conference call on Tuesday, March 01, 2022, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live...

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and Charlie Webster, Executive Vice President, are scheduled to present at the CJS Securities 22 nd Annual New Ideas for the New Year Investor Conference, which is being held virtually, on Wednesday, January 12, 2022. About Novanta Novanta is a leading global supplier of core technology solutions that...

Novanta Inc. (Nasdaq:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chairperson and Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the J.P. Morgan Healthcare Conference, which is being held in person, on Tuesday, January 11, 2022, in San Francisco, California. About Novanta Novanta is a leading global supplier of core technology solutions that...

Novanta Inc. (Nasdaq:NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2021. Financial Highlights Three Months Ended (In millions, except per share amounts) October 1, October 2, 2021 2020 GAAP Revenue $ 177.7 $ 142.9 Operating Income $ 15.3 $ 11.9 Consolidated Net Income $ 13.6 $ 8.3 Diluted EPS $ 0.38 $ 0.23 Non-GAAP* Adjusted Operating Income $ 31.6 $ 19.9 Adjusted Diluted...

Novanta Inc. (Nasdaq:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chairperson and Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the Baird's 2021 Global Industrial Conference on Wednesday, November 10, 2021, which is being held virtually. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and...

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2021 results on Tuesday, November 09, 2021. The Company will host a conference call on Tuesday, November 09, 2021, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the...

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chairperson and Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the Baird's 2021 Global Healthcare Conference on Wednesday, September 15, 2021, which is being held virtually. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and...

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has completed the acquisitions of Schneider Electric Motion USA Inc. (“SEM”) and ATI Industrial Automation Inc. (“ATI”). "SEM and ATI are fantastic businesses which are excellent strategic additions to Novanta, expanding our positions in high growth markets,” said Matthijs Glastra, Chairperson and CEO of Novanta. “With the...

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the second quarter 2021. Financial Highlights Three Months Ended (In millions, except per share amounts) July 2, July 3, 2021 2020 GAAP Revenue $ 167.5 $ 144.7 Operating Income $ 16.0 $ 13.7 Consolidated Net Income $ 11.7 $ 11.7 Diluted EPS $ 0.33 $ 0.33 Non-GAAP* Adjusted Operating Income $ 28.7 $ 22.1 Adjusted Diluted EPS...

Harris Williams , a global investment bank specializing in M&A advisory services, announces it is advising ATI Industrial Automation (ATI) on its pending sale to Novanta Inc. (Nasdaq: NOVT; Novanta). Headquartered in Apex, North Carolina, ATI is a leading global developer and manufacturer of robot end-effector products. The transaction is being led by John Arendale , Jeff Perkins , Brandt Carr , Jenson Dunn and Caroline Inglesby of the Harris Williams Industrials Group . “We are honored to...

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has reached an agreement to acquire privately held ATI Industrial Automation ("ATI") for $172 million upfront in cash and additional contingent cash payments associated with 2021 financial performance. In addition, to further incentivize future financial performance, the Company will also grant performance stock units. The transaction is...